Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Pegylated Liposomal Doxorubicin and Docetaxel in Breast Cancer
NCT00524459Phase 2Terminated
- Sponsor
- Roswell Park Comprehensive Cancer Center
- Start
- May 2007
- Primary completion
- Aug 2008
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of doxorubicin, docetaxel in breast cancer, sponsored by Roswell Park Comprehensive Cancer Center. Started May 2007; status: terminated.
02
Drugs
doxorubicindocetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00524459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00524459.